How can you knock an aussie bio with a near approved FDA...

How can you knock an aussie bio with a near approved FDA approved product already generating circa 2 mill per annum in proven overseas markets?

Whilst yes it's not shooting the lights out, we are valued under 300 mill with a revenue generating product that will receive FDA approval in June.

Cu6 and the like are valued in excess of 500 million with phase 3 trials.

We also have acne going into phase 3 and antibiotic arms going into phase 2B.

The market is completely missing this at present. Based on numbers this will push towards the $1bill valuation post FDA approval.

The run to 30 cents begins shortly.